z-logo
open-access-imgOpen Access
Omalizumab for management of refractory urticaria: Experience of a tertiary care centre in Eastern India
Author(s) -
Shekhar Neema,
Manas Chatterjee
Publication year - 2018
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_342_16
Subject(s) - omalizumab , medicine , refractory (planetary science) , chronic urticaria , tertiary care , retrospective cohort study , pediatrics , surgery , immunoglobulin e , antibody , immunology , physics , astrobiology
To study the effects of omalizumab in chronic spontaneous urticaria in Indian patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here